Brief: Alphamab Oncology Announces Technology Development Collaboration With Suzhou Alphamab
26/05/2021 16:03
May 26 (Reuters) - Alphamab Oncology 9966.HK :
* ANNOUNCES TECHNOLOGY DEVELOPMENT COLLABORATION WITH SUZHOU
ALPHAMAB
* COLLABORATION WITH SUZHOU ALPHAMAB ON JSKN003 PROJECT AND
KN062
COVID-19 ANTIBODY PROJECT
Source text https://www1.hkexnews.hk/listedco/listconews/sehk/2021/0526/2021052601491.pdf
Further company coverage: 9966.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Alphamab Oncology
See all newsBrief: Alphamab Oncology Says Fei Wang Resigns As Chief Financial Officer
Brief: Alphamab Oncology Says First Patient Dosed In Phase III Clinical Study Of JSKN033 Monotherapy For Treatment Of Cervical Cancer
Brief: Alphamab Oncology Says Board Resolves To Repurchase Shares Up To HK$80 Million In Value
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab With HB1801 For Her2+ Advanced Breast Cancer
Brief: Alphamab Oncology Says NMPA Accepts NDA For Anbenitamab (KN026)